{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T22:32:14Z","timestamp":1774477934216,"version":"3.50.1"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81573203, 81973099"],"award-info":[{"award-number":["No. 81573203, 81973099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Carbapenemase-producing <jats:italic>Klebsiella pneumoniae<\/jats:italic> (CpKP) has been implicated as an increasing threat to public health. CpKP is a ubiquitous, opportunistic pathogen that causes both hospital and community acquired infections. This organism hydrolyzes carbapenems and other \u03b2-lactams and thus, leading to multiple resistance to these antibiotics. Despite the difficult to treat nature of infections caused by CpKP, little has been discussed on the mortality, clinical response and microbiological success rates associated with various antibiotic regimen against CpKP. This meta-analysis was designed to fill the paucity of information on the clinical impact of various antibiotic therapeutic regimens among patients infected with CpKP.<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> Literature in most English databases such as Medline through PubMed, Google Scholar, Web of Science, Cochrane Library and EMBASE, were searched for most studies published between the years 2015\u20132020. Data were analyzed using the R studio 2.15.2 statistical software program (metaphor and meta Package, Version 2) by random-effects (DerSimonian and Laird) model.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Twenty-one (21) studies including 2841 patients who had been infected with CpKP were analysed. The overall mortality rate was 32.2% (95%<jats:italic>CI<\/jats:italic> = 26.23\u201338.87; <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup> = 89%; <jats:italic>p<\/jats:italic>-value \u2264 0.01, Number of patients = 2716). Pooled clinical and microbiological success rates were 67.6% (95%<jats:italic>CI<\/jats:italic> = 58.35\u201375.64, <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup> = 22%, <jats:italic>p<\/jats:italic>-value = 0.25, Number of patients = 171) and 74.9% (95%<jats:italic>CI<\/jats:italic> = 59.02\u201386.09, <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup> = 53%, <jats:italic>p<\/jats:italic>-value = 0.05, Number of patients = 121), respectively. CpKP infected patients treated with combination therapy are less likely to die as compared to those treated with monotherapy (OR = 0.55, 95%<jats:italic>CI<\/jats:italic> = 0.35\u20130.87, <jats:italic>p<\/jats:italic>-value = 0.01, Number of patients = 1,475). No significant difference existed between the mortality rate among 60years and above patients vs below 60years (OR = 0.84, 95%<jats:italic>CI<\/jats:italic> = 0.28\u20132.57, <jats:italic>p<\/jats:italic>-value = 0.76, 6 studies, Number of patients = 1,688), and among patients treated with triple therapy vs. double therapy (OR = 0.50, 95%<jats:italic>CI<\/jats:italic> = 0.21\u20131.22, <jats:italic>p<\/jats:italic>-value = 0.13, 2 studies, Number of patients = 102). When compared with aminoglycoside-sparing therapies, aminoglycoside-containing therapies had positive significant outcomes on both mortality and microbiological success rates.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> New effective therapies are urgently needed to help fight infections caused by this organism. The effective use of various therapeutic options and the strict implementation of infection control measures are of utmost importance in order to prevent infections caused by CpKP. Strict national or international implementation of infection control measures and treatment guidelines will help improve healthcare, and equip governments and communities to respond to and prevent the spread of infectious diseases caused by CpKP.<\/jats:p>","DOI":"10.3389\/fphar.2021.597907","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T06:11:53Z","timestamp":1636006313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of the Therapeutic Outcomes of Antibiotic Regimen Against Carbapenemase-Producing Klebsiella pneumoniae: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Clement Yaw","family":"Effah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel Kwateng","family":"Drokow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement","family":"Agboyibor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Nuamah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4067\/s0716-10182016000200006","article-title":"Colist\u00edn en la era post-antibi\u00f3tica","volume":"33","author":"Aguayo","year":"2016","journal-title":"Rev. Chil. Infectol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/cid\/cit453","article-title":"Higher Incidence of Acute Kidney Injury with Intravenous Colistimethate Sodium Compared with Polymyxin B in Critically Ill Patients at a Tertiary Care Medical center","volume":"57","author":"Akajagbor","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jinf.2016.10.002","article-title":"Double-Carbapenem Regimen, Alone or in Combination With Colistin, in the Treatment of Infections Caused by Carbapenem-Resistant Klebsiella Pneumoniae (CR-Kp)","volume":"74","author":"Alexandra","year":"2016","journal-title":"J. Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/00365548.2013.861608","article-title":"Tigecycline Therapy for Infections Due to Carbapenemase-Producing Klebsiella pneumoniae in Critically Ill Patients","volume":"46","author":"Balandin Moreno","year":"2014","journal-title":"Scand. J. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jgar.2019.01.020","article-title":"Prevalence of Extended-Spectrum \u03b2-lactamase-producing Klebsiella pneumoniae: First Systematic Review and Meta-Analysis from Iran","volume":"18","author":"Beigverdi","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B5","doi-asserted-by":"publisher","first-page":"pii=20809","DOI":"10.2807\/1560-7917.es2014.19.20.20809","article-title":"New Delhi Metallo-Beta-Lactamase Around the World: an eReview Using Google Maps","volume":"19","author":"Berrazeg","year":"2014","journal-title":"Euro Surveill."},{"key":"B6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.bmcl.2013.12.101","article-title":"Discovery of MK-7655, a \u03b2-lactamase Inhibitor for Combination with Primaxin\u00ae","volume":"24","author":"Blizzard","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/9780470743386","author":"Borenstein","year":"2009","journal-title":"Introduction to Meta-Analysis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","article-title":"Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City: a New Threat to Our Antibiotic Armamentarium","volume":"165","author":"Bratu","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1128\/AAC.01420-10","article-title":"Double-carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae","volume":"55","author":"Bulik","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid Evolution and Spread of Carbapenemases Among Enterobacteriaceae in Europe","volume":"18","author":"Cant\u00f3n","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e00567","DOI":"10.1128\/AAC.00567-17","article-title":"Meropenem-vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1128\/AAC.00711-16","article-title":"Effect of the \u03b2-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae","volume":"60","author":"Castanheira","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/mdr.2009.0031","article-title":"Antimicrobial Susceptibility Patterns of KPC-Producing or CTX-M-Producing Enterobacteriaceae","volume":"16","author":"Castanheira","year":"2010","journal-title":"Microb. Drug Resist."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1128\/AAC.00188-13","article-title":"Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae","volume":"57","author":"Ceccarelli","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/imj.12863","article-title":"Managing a Nosocomial Outbreak of Carbapenem-Resistant Klebsiella pneumoniae: an Early Australian Hospital Experience","volume":"45","author":"Chang","year":"2015","journal-title":"Intern. Med. J."},{"key":"B16","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. CLSI Document M100-S25","year":"2015"},{"key":"B17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jhin.2007.10.011","article-title":"Evaluation of Risk Factors for the Acquisition of Bloodstream Infections with Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Species in the Intensive Care Unit; Antibiotic Management and Clinical Outcome","volume":"68","author":"Cordery","year":"2008","journal-title":"J. Hosp. Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1128\/AAC.01569-15","article-title":"Ertapenem-containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae","volume":"60","author":"Cprek","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3201\/eid1609.091389","article-title":"Worldwide Diversity of Klebsiella pneumoniae that Produce Beta-Lactamase blaKPC-2 Gene","volume":"16","author":"Cuzon","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/jam.12171","article-title":"Prevalence of NDM-1 Carbapenemase in Patients with Diarrhoea in Pakistan and Evaluation of Two Chromogenic Culture media","volume":"114","author":"Day","year":"2013","journal-title":"J. Appl. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1128\/AAC.03042-15","article-title":"In Vitro susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)","volume":"60","author":"de Jonge","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cmi.2014.07.010","article-title":"Treatment of KPC-Producing Enterobacteriaceae: Suboptimal Efficacy of Polymyxins","volume":"21","author":"De Oliveira","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13054-017-1769-z","article-title":"Double Carbapenem as a rescue Strategy for the Treatment of Severe Carbapenemase-Producing Klebsiella pneumoniae Infections: a two-center, Matched Case-Control Study","volume":"21","author":"De Pascale","year":"2017","journal-title":"Crit. Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-019-0343-8","article-title":"Klebsiella pneumoniae: an Increasing Threat to Public Health","volume":"19","author":"Effah","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B26","unstructured":"Surveillance of Antimicrobial Resistance in Europe \u2013 Annual Report2017"},{"key":"B27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/cid\/cir934","article-title":"What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression","volume":"54","author":"Florescu","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s15010-015-0743-4","article-title":"Risk Factors and Outcome of Infections with Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Kidney Transplant Recipients","volume":"43","author":"Freire","year":"2015","journal-title":"Infection"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1128\/AAC.02399-12","article-title":"Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae","volume":"57","author":"Giamarellou","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijantimicag.2017.08.019","article-title":"Effect of Combination Therapy Containing a High-Dose Carbapenem on Mortality in Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection","volume":"51","author":"Giannella","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/1469-0691.12325","article-title":"High Rate of Faecal Carriage of Extended-Spectrum \u03b2-lactamase and OXA-48 Carbapenemase-Producing Enterobacteriaceae at a university Hospital in Morocco","volume":"20","author":"Girlich","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jac\/dku432","article-title":"Gentamicin Therapy for Sepsis Due to Carbapenem-Resistant and Colistin-Resistant Klebsiella pneumoniae","volume":"70","author":"Gonzalez-Padilla","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B102","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijantimicag.2018.10.010","article-title":"Combination Therapy With Polymyxin B for Carbapenemase-Producing Klebsiella Pneumoniae Bloodstream Infection","volume":"53","author":"Gregory","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e00528","DOI":"10.1128\/AAC.00528-19","article-title":"Ceftazidime-avibactam as Salvage Therapy for Infections Caused by Enterobacteriales Coresistant to Carbapenems and Polymyxins","volume":"63","author":"Guimar\u00e3es","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of Appropriate Combination Therapy on Mortality of Patients with Bloodstream Infections Due to Carbapenemase-Producing Enterobacteriaceae (INCREMENT): a Retrospective Cohort Study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e01968","DOI":"10.1128\/AAC.01968-17","article-title":"In Vitro activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016","volume":"62","author":"Hackel","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/jac\/dkq108","article-title":"Detection and Treatment Options for Klebsiella pneumoniae Carbapenemases (KPCs): an Emerging Cause of Multidrug-Resistant Infection","volume":"65","author":"Hirsch","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","first-page":"165","article-title":"Vital Signs: Carbapenem-Resistant Enterobacteriaceae","volume":"62","author":"Jacob","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1099\/jmm.0.052555-0","article-title":"Global Spread of Antibiotic Resistance: the Example of New Delhi Metallo-\u03b2-Lactamase (NDM)-mediated Carbapenem Resistance","volume":"62","author":"Johnson","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/phar.1636","article-title":"Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management","volume":"35","author":"Kaye","year":"2015","journal-title":"Pharmacotherapy"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1128\/JCM.02466-08","article-title":"Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection","volume":"47","author":"Lee","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1179\/1973947812Y.0000000062","article-title":"Detection, Treatment, and Prevention of Carbapenemase-Producing Enterobacteriaceae: Recommendations from an International Working Group","volume":"25","author":"Levy Hara","year":"2013","journal-title":"J. Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3892\/etm.2017.4046","article-title":"Retrospective Analysis of Fosfomycin Combinational Therapy for Sepsis Caused by Carbapenem-Resistant Klebsiella pneumoniae","volume":"13","author":"Liao","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","article-title":"Resurgence of Colistin: a Review of Resistance, Toxicity, Pharmacodynamics, and Dosing","volume":"30","author":"Lim","year":"2010","journal-title":"Pharmacotherapy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/jac\/dkw593","article-title":"In Vitro activity of Cefepime\/zidebactam (WCK 5222) against Gram-Negative Bacteria","volume":"72","author":"Livermore","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/jac\/dkq408","article-title":"Activity of Aminoglycosides, Including ACHN-490, against Carbapenem-Resistant Enterobacteriaceae Isolates","volume":"66","author":"Livermore","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e00406","DOI":"10.1128\/AAC.00406-17","article-title":"Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems","volume":"61","author":"Machuca","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"Plos Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical Epidemiology of the Global Expansion of Klebsiella pneumoniae Carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/femsre\/fux013","article-title":"Klebsiella pneumoniae: a Major Worldwide Source and Shuttle for Antibiotic Resistance","volume":"41","author":"Navon-Venezia","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e00989","DOI":"10.1128\/AAC.00989-17","article-title":"Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity","volume":"61","author":"Nelson","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cmi.2015.09.014","article-title":"Bactericidal and Synergistic Activity of Double-Carbapenem Regimen for Infections Caused by Carbapenemase-Producing Klebsiella pneumoniae","volume":"22","author":"Oliva","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1093\/jac\/dkx084","article-title":"In Vitro evaluation of Different Antimicrobial Combinations against Carbapenemase-Producing Klebsiella pneumoniae: the Activity of the Double-Carbapenem Regimen Is Related to Meropenem MIC Value","volume":"72","author":"Oliva","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4067\/s0716-10182017000100001","article-title":"Factores asociados a nefrotoxicidad por polimixina B en un hospital universitario de Neiva, Colombia. 2011-2015","volume":"34","author":"Osorio","year":"2017","journal-title":"Rev. Chil. Infectol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10096-017-2899-6","article-title":"Carbapenemase-producing Klebsiella pneumoniae Bloodstream Infection in Critically Ill Patients: Risk Factors and Predictors of Mortality","volume":"36","author":"Papadimitriou-Olivgeris","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1086\/313559","article-title":"Extended-spectrum Beta-Lactamases: a Call for Improved Detection and Control","volume":"29","author":"Paterson","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2147\/IDR.S150447","article-title":"Overview of Meropenem-Vaborbactam and Newer Antimicrobial Agents for the Treatment of Carbapenem-Resistant Enterobacteriaceae","volume":"11","author":"Petty","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"B60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum Beta-Lactamase-Producing Enterobacteriaceae: an Emerging Public-Health Concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1128\/CMR.11.4.589","article-title":"Klebsiella Spp. As Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors","volume":"11","author":"Podschun","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1128\/AAC.00585-11","article-title":"Genetic Features of blaNDM-1-Positive Enterobacteriaceae","volume":"55","author":"Poirel","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/jac\/dkv294","article-title":"In Vitro evaluation of Dual Carbapenem Combinations against Carbapenemase-Producing Enterobacteriaceae","volume":"71","author":"Poirel","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s00134-017-4796-y","article-title":"\"Salvage Treatment\" for Infections by Extensively- and Pan-Drug-Resistant Pathogens Is Common and Often Sub-optimal","volume":"43","author":"Poulakou","year":"2017","journal-title":"Intensive Care Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1128\/JCM.00459-12","article-title":"Imported Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Clones in a Greek Hospital: Impact of Infection Control Measures for Restraining Their Dissemination","volume":"50","author":"Poulou","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/AAC.06268-11","article-title":"Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens","volume":"56","author":"Qureshi","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e00079","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae","volume":"31","author":"Rodr\u00edguez-Ba\u00f1o","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12795","article-title":"\u201cDouble Carbapenem\u201d and Oral Fosfomycin for the Treatment of Complicated Urinary Tract Infections Caused by blaNDM -Harboring Enterobacteriaceae in Kidney Transplantation.","volume":"20","author":"Rosa","year":"2018","journal-title":"Transpl. Infect Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e02163","DOI":"10.1128\/AAC.02163-17","article-title":"Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects","volume":"62","author":"Saisho","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1128\/AAC.00387-11","article-title":"Comparative Effectiveness of Aminoglycosides, Polymyxin B, and Tigecycline for Clearance of Carbapenem-Resistant Klebsiella pneumoniae from Urine","volume":"55","author":"Satlin","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/cid\/cis969","article-title":"Carbapenem-sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit","volume":"56","author":"Sbrana","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/jac\/dkx496","article-title":"Clinical Outcomes after Combination Treatment with Ceftazidime\/avibactam and Aztreonam for NDM-1\/oxa-48\/ctx-M-15-Producing Klebsiella pneumoniae Infection","volume":"73","author":"Shaw","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1086\/649865","article-title":"An Outbreak of Infection Due to Beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes","volume":"50","author":"Souli","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s10096-017-2936-5","article-title":"Double-carbapenem Combination as Salvage Therapy for Untreatable Infections by KPC-2-Producing Klebsiella pneumoniae","volume":"36","author":"Souli","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijantimicag.2015.12.021","article-title":"New Drugs for the Treatment of Complicated Intra-abdominal Infections in the Era of Increasing Antimicrobial Resistance","volume":"47","author":"Syue","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B76","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination Therapy for Treatment of Infections with Gram-Negative Bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"8096420","DOI":"10.1155\/2017\/8096420","article-title":"Add-on Therapy with Ertapenem in Infections with Multidrug Resistant Gram-Negative Bacteria: Pediatric Experience","volume":"2017","author":"Tan\u0131r Basaranoglu","year":"2017","journal-title":"Case Rep. Infect. Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/antibiotics8010032","article-title":"Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens","volume":"8","author":"Thomson","year":"2019","journal-title":"Antibiotics"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ajh.24489","article-title":"Bloodstream Infections Caused by Klebsiella pneumoniae in Onco-Hematological Patients: Clinical Impact of Carbapenem Resistance in a Multicentre Prospective Survey","volume":"91","author":"Trecarichi","year":"2016","journal-title":"Am. J. Hematol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1128\/AAC.50.2.498-504.2006","article-title":"Bloodstream Infections Caused by Extended-Spectrum-Beta-Lactamase-Producing Klebsiella pneumoniae: Risk Factors, Molecular Epidemiology, and Clinical Outcome","volume":"50","author":"Tumbarello","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B81","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/cid\/ciy492","article-title":"Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae","volume":"68","author":"Tumbarello","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/jac\/dkv086","article-title":"Infections Caused by KPC-Producing Klebsiella pneumoniae: Differences in Therapy and Mortality in a Multicentre Study","volume":"70","author":"Tumbarello","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/jac\/dkv200","article-title":"Infections Caused by KPC-Producing Klebsiella pneumoniae: Differences in Therapy and Mortality in a Multicentre Study-Aauthors' Response","volume":"70","author":"Tumbarello","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"B84","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy","volume":"55","author":"Tumbarello","year":"","journal-title":"Clin. Infect. Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy","volume":"55","author":"Tumbarello","year":"","journal-title":"Clin. Infect. Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/1469-0691.12697","article-title":"Treating Infections Caused by Carbapenemase-Producing Enterobacteriaceae","volume":"20","author":"Tzouvelekis","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B87","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"B88","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/23744235.2017.1350880","article-title":"Double Carbapenem Therapy (DCT) for Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae (CRKP): from Test Tube to Clinical Practice","volume":"49","author":"Venugopalan","year":"2017","journal-title":"Infect. Dis. (Lond)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1128\/AAC.01405-06","article-title":"First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-type Carbapenem-Hydrolyzing Beta-Lactamase","volume":"51","author":"Villegas","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B90","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fmicb.2013.00392","article-title":"Novel \u03b2-lactamase Inhibitors: a Therapeutic hope against the Scourge of Multidrug Resistance","volume":"4","author":"Watkins","year":"2013","journal-title":"Front. Microbiol."},{"key":"B91","volume-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analysis","author":"Wells","year":"2004"},{"key":"B92","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ijantimicag.2013.02.015","article-title":"Impact of Various Conditions on the Efficacy of Dual Carbapenem Therapy against KPC-Producing Klebsiella pneumoniae","volume":"41","author":"Wiskirchen","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B93","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s40265-017-0725-1","article-title":"Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy","volume":"77","author":"Wong","year":"2017","journal-title":"Drugs"},{"key":"B94","volume-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics","year":"2017"},{"key":"B95","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cmi.2017.09.001","article-title":"New Agents for the Treatment of Infections with Gram-Negative Bacteria: Restoring the Miracle or False Dawn?","volume":"23","author":"Wright","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"B96","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic Review and Meta-Analysis of Mortality of Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae","volume":"16","author":"Xu","year":"2017","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel Carbapenem-Hydrolyzing Beta-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","article-title":"Predictors of Mortality in Patients with Bloodstream Infections Caused by KPC-Producing Klebsiella pneumoniae and Impact of Appropriate Antimicrobial Treatment","volume":"17","author":"Zarkotou","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1586\/14787210.2013.845523","article-title":"Combination Therapy for Carbapenem-Resistant Gram-Negative Bacteria","volume":"11","author":"Zavascki","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40265-017-0851-9","article-title":"Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-\u03b2-Lactamase Inhibitor Combinations","volume":"78","author":"Zhanel","year":"2018","journal-title":"Drugs"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/bmt.2010.279","article-title":"SCT in Patients with Carbapenem Resistant Klebsiella pneumoniae: a Single center Experience with Oral Gentamicin for the Eradication of Carrier State","volume":"46","author":"Zuckerman","year":"2011","journal-title":"Bone Marrow Transpl."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.597907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T06:11:59Z","timestamp":1636006319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.597907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":101,"alternative-id":["10.3389\/fphar.2021.597907"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.597907","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]},"article-number":"597907"}}